advanced

Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting

Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort…

1 month ago

Revolutionizing Prescription Management: Ironsail Pharma Launches Advanced Pharmacy Network Technology

New York, New York, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ironsail Pharma is excited to announce the launch of its…

1 month ago

Sonrai Accelerates Cancer Therapeutics Research with Advanced Analytics

BELFAST, Northern Ireland, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonrai Analytics (Sonrai), an AI precision medicine company providing advanced analytics…

2 months ago

Greentank and Advanced Inhalation Rituals Partner on First-of-Its-Kind Wellness Inhalable Device

TORONTO, Oct. 30, 2024 /PRNewswire/ -- Greentank Technologies today announced it has entered into a partnership with Advanced Inhalation Rituals (AIR…

2 months ago